{"id":"W4406943114","doi":"10.1016/j.cllc.2025.01.011","title":"Efficacy and Safety of Atezolizumab in Chinese Patients With Advanced Thymic Carcinoma: A Multicenter, Single-Arm Phase 2 Study","year":2025,"lang":"en","type":"article","venue":"Clinical Lung Cancer","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"F. Hoffmann-La Roche; Roche Canada","keywords":"Medicine; Atezolizumab; Internal medicine; Adverse effect; Clinical endpoint; Thymic carcinoma; Phases of clinical research; Carcinoma; Oncology; Toxicity; Gastroenterology; Surgery; Cancer; Clinical trial; Chemotherapy; Immunotherapy; Pembrolizumab","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001992042,0.0001841443,0.0006766466,0.00009788135,0.00003361559,0.000006670227,0.00008773262,0.0000740317,0.00004450973],"category_scores_gemma":[0.0002575415,0.000122914,0.00006955963,0.000299938,0.0001256176,0.00004705058,0.00007704568,0.0002621723,7.713923e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009395428,"about_ca_system_score_gemma":0.0001211032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000105124,"about_ca_topic_score_gemma":0.0001852428,"domain_scores_codex":[0.99836,0.00009189756,0.0007413449,0.0004122657,0.0001835105,0.000210992],"domain_scores_gemma":[0.9989678,0.0002857261,0.0001603668,0.0003388103,0.0001292204,0.000118084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02078771,0.01270791,0.9211537,0.0001459771,0.0001334476,0.00002303943,0.0003135791,0.000005436653,0.00003948517,0.000008876257,0.00002844019,0.04465241],"study_design_scores_gemma":[0.09193435,0.004108477,0.9024307,0.0005500395,0.0002139724,4.891163e-7,0.0000631053,0.0003837856,0.00001694279,0.000006415853,0.0001882191,0.0001035123],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9962755,0.001106402,0.0000129873,0.0001747798,0.000249624,0.001813602,0.00002786798,0.00001804915,0.0003211178],"genre_scores_gemma":[0.9993603,0.00008910098,0.0001032875,0.0001943066,0.00004512099,0.00005177636,0.00001594669,0.00001828739,0.0001219235],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07114664,"threshold_uncertainty_score":0.5012288,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01500235137361954,"score_gpt":0.3897684187349703,"score_spread":0.3747660673613507,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}